A resolution expressing support for the designation of July 15, 2024, as "National Leiomyosarcoma Awareness Day".

Bill: 118-sres-775
Sponsor: full_name: Sen. Stabenow, Debbie [D-MI]
Introduced: 2024-07-30
Policy area: Health
Latest action: action_date: 2024-07-30
text: Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5587-5588)

Summaries:
action_date: 2024-07-30
action_desc: Introduced in Senate
text: <p>This resolution supports the designation of July 15, 2024, as National Leiomyosarcoma Awareness Day.</p>

tv_txt: III 118th CONGRESS 2d Session S. RES. 775 IN THE SENATE OF THE UNITED STATES July 30, 2024 Ms. Stabenow submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and Pensions RESOLUTION Expressing support for the designation of July 15, 2024, as “National Leiomyosarcoma Awareness Day”.

Whereas leiomyosarcoma is a malignant sarcoma subtype, 1 of 70 to 100 such subtypes, that arises in smooth muscle and has several subtypes itself due to its vascularity and bone invasion; Whereas leiomyosarcoma is designated by the National Institutes of Health as a rare form of cancer; Whereas leiomyosarcoma is largely resistant to standard chemotherapy treatments, radiation treatments, and immunotherapy trials, with 40-year-old chemotherapy treatments still in use; Whereas leiomyosarcoma affects all age groups, including children, young adults, the middle-aged, and the elderly, and all genders; Whereas leiomyosarcoma is diagnosed in more than 2,000 individuals in the United States each year; Whereas, with respect to leiomyosarcoma, research and clinical trials remain complicated and extremely costly due to the difficulty of recruiting patients; Whereas survival and longevity for individuals with leiomyosarcoma has not significantly improved for at least 30 years; Whereas multidisciplinary care coordination teams, because of their expertise and experience, are critical to the health of leiomyosarcoma patients; Whereas researchers continue to strive to improve quality of life for leiomyosarcoma patients, improve outcomes in clinical trials, and promote enhanced survivorship; and Whereas increased education and awareness about sarcoma and leiomyosarcoma will contribute to the well-being of the communities of the United States: Now, therefore, be it

That the Senate— (1) supports the designation of July 15, 2024, as National Leiomyosarcoma Awareness Day ; (2) recognizes the challenges faced by leiomyosarcoma patients; and (3) commends the dedication of organizations, volunteers, researchers, and caregivers across the United States working to improve the quality of life of leiomyosarcoma patients and their families.